Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-12-27
2005-12-27
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C556S137000, C546S002000, C514S492000
Reexamination Certificate
active
06979681
ABSTRACT:
Ruthenium (II) compounds of the formula:wherein: R1is —CO2CH3; R2, R3, R4, R5and R6independently represent H, alkyl, cylcoalkyl, —CO2R′, aryl or alkylaryl, which latter two groups are optionally substituted on the aromatic ring; R′ represents alkyl, cylcoalkyl, aryl or alkaryl; X is halo, H2O, (R′)(R″)SO, R′CO2−or (R′)(R″)C═O, where R″ represents alkyl, cylcoalkyl, aryl or alkaryl; Y is a counterion; m is 0 or 1; q is 1, 2 or 3; C′ is C1to C12alkylene, optionally substituted in or on the alkylene chain, bound to two A groups; p is 0 or 1 and r is 1 when p is 0 and r is 2 when p is 1; and A and B are: each independently R11—CN, where R″ represents alkyl or cycloalkyl; or B is halo and A is 4-substitued pyridine; or p is 0, A is NR7R8and B is NR9R10wherein R7, R8, R9and R10independently represent H, or alkyl, and A and B are linked by an alkylene chain, optionally substituted in or on the alkylene chain; or p is 1, A is NR7and B is NR9R10, wherein R7, R9and R10are as previously defined, and A and B are linked by an alkylene chain, optionally substituted are described.
REFERENCES:
patent: 4699978 (1987-10-01), Barton
patent: 4843069 (1989-06-01), Keller et al.
patent: 4980472 (1990-12-01), Tomcufcik et al.
patent: 5225556 (1993-07-01), Barton
patent: 5386044 (1995-01-01), Dembek
patent: 5708022 (1998-01-01), Bastos et al.
patent: 11209314 (1999-08-01), None
patent: WO 86/00804 (1986-02-01), None
patent: WO 96/133510 (1996-05-01), None
patent: WO 200130790 (2001-05-01), None
patent: WO 200202572 (2002-01-01), None
patent: WO 02/40494 (2002-05-01), None
Yann Hung, Inorganic Chemistry 20(2), 1981 pp 457-463.
Robert E. Morris, et al J. Med. Chem.; 2001; 44(22) pp 3616-3621.
Susan S. Alguindigue, et al Organometallics; 1999; 18(24) pp 5112-5119.
Fred B. McCormick, Organometallics 12(3), 1993 pp 610-612.
Roger Mahe, J. Organic chemistry 54(7), 1989 pp. 1518-1523.
Cetinkaya, Journal of Materials Chemistry 8(8) 1835-1838, 1988.
Arthur, J. Organometallic Chemistry 208(3) 369-387 1981.
Aird et al., “In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer,” British Journal of Cancer 86:1652-1657 (2002).
Aronson et al., “The Reactions of [Ru(η6-arene)Cl2]2Compounds with a Series of Aminopyridine Ligands:X-Ray Crystal Structures of [Ru(η6-1,4-MeC6H4CHMe2Cl2(NC5H4NH2)] And Ru[η6-C16H16)CL2(NC5H4NH2)],” Polyhedron 10(15):1727-1732 (1991).
Beasley et al., “Complexation of 1,4,5,8,9,10-Hexahydroanthracene (HHA) to Iron or Ruthenium: A Bis(diene)diiron HHA Geometry, Hydroaromatic Ruthenium Compounds Related to RU(η6-THA)CL2(DMSO) (THA = 1,4,9,10-Tetrahydroanthracene; DMSO = Dimethyl Sulfoxide), and Ru3(CO)12-Catalyzed HHA Rearrangements,” Organometallics 12:4599-4606 (1993).
Bennett et al., “Arene Ruthenium(II) Complexes formed by Dehydrogenation of Cyclohexadienes with Ruthenium(III) Trichloride,” J.C.S. Dalton 233-241 (1974).
Bennett et al., “Mono- and bis-(acetylacetonato) complexes of arene-ruthenium(II) and arene-osmium(II): variation of the binding mode of η1-acetylacetonate with the nature of the arene,” Can. J. Chem. 79:655-669 (2001).
Carmona et al., “Synthesis, X-Ray Structure, and Nuclear Magnetic Resonance (1H and13C) Studies of Ruthenium(II) Complexes containing Pyrazolyl Ligands,” J. Chem. Soc. Dalton Trans. 1463-1476 (1990).
Cetinkaya et al., “Antibacterial and Antifungal Activities of Complexes of Ruthenium(II),” Arzneim.-Forschl./Drug Res. 49(1)(6):538-540 (1999).
Chen et al., “Organometallic Ruthenium(II) Diamine Anticancer Complexes: Arene-Nucleobase Stacking and Stereospecific Hydrogen-Bonding in Guanine Adducts,” J. Am. Chem. Soc. 124(12):3064-3082 (2002).
Clarke et al., “Non-Platinum Chemotherapeutic Metallopharmaceuticals,” Chem. Rev. 99:2511-2533 (1999).
Crabtree et al., “Arene-Ruthenium Complexes Containing Nitrogen Donor Ligands,” Journal of Organometallic Chemistry 141:325-330 (1977).
Cummings et al., “Novel ruthenium (Ru11) organo-metallic complexes: in vitro cytotoxicity in wild type and drug resistant A2780 human ovarian cancer cell lines,” Clinical Cancer Research 6 (Suppl.) (2000).
Dale et al., “Studies on DNA damage and induction of SOS repair by novel multifunctional bioreducible compounds. II. A metronidazole adduct of a ruthenium-arene compound,” Anti-Cancer Drug Design 7:3-14 (1992).
Drew et al., “Transistion Metal-Diene Complexes. Part 4. The Crystal and Molecular Strcture and Isomerization of η-Cyclopentadienyl (η-3-methoxycarbonyl-cyclohexa-1,4-diene)rhodium(I),” J.C.S. Dalton:1034-1040 (1981).
Elsegood et al., “The synthesis of new paracyclophane complexes of ruthenium(II): Crystal structure of [Ru(η6C16H16)CI(C5H5N)2][PF6],” Journal of Organometallic Chemistry 356:C29-C31 (1988).
Garcia et al., “Reactivity of [{(η6-arene)RuCl(μ-Cl)}2] towards some potentially bidentate ligands. Molecular structure of [η6-p-cymene)RuCI(taz)]PF6(p-cymene=p-McC6H4CH-Me2; taz=2,6-dimethyl-5-oxo-3-thioxo-2,3,4,5-tetrahydro-1,2,4-triazine),” Journal of Organometallic Chemistry 467:119-126 (1994).
Gleichmann et al., “η5-Pentamethylcyclopentadienylruthenium(II) Complexes containing η6-Co-ordinated Dipeptides with Aromatic Side Chains,” J. Chem. Soc. Dalton Trans. 1549-1554 (1995).
Guo et al., “Chelate ring-opening ruthenium-complexes: X-ray crystal structure and solution studies ofcis. trans-bis (2-dimethyl-aminoethyl)-diphenyl-phosphino(dichloro)ruthenium(II),” Inorganica Chimica Acta 273:1-7 (1998).
Gupta et al., “Synthesis, characterization, reactivity and structure of some mono and binuclear (η6-p-cymene)ruthenium(II) complexes,” Journal of Organometallic Chemistry 568:13-20 (1998).
Harvey “Metal-Ammonia Reduction of Aromatic Molecules,” Synthesis 4:161-172 (Apr. 1970).
Hung et al., “Aquo Chemistry of Monoarene Complexes of Osmium(II) and Ruthenium(II),” Inorganic Chemistry 20(2):457-463 (1981).
Jensen et al., “Facile prepration of η6-p-cymene ruthenium diphosphine complexes. Crystal structure of [(η6-p-cymene)Ru(dppf)C1]PF6,” Journal of Organometallic Chemistry 556:151-158 (1998).
Korn et al., “Oligomeric (η6-arene ruthenium(II) complexes of adenine and adenosine with N6,N7 coordination,” Inorganica Chimica Acta 254:85-91 (1997).
Krämer et al., “Applications of x-Arene-Ruthenium Complexes in Peptide Labeling and Peptide Synthesis,” Angew. Chem. Int. Ed. Engl. 35(11):1197-1554 (1996).
Krämer et al., “Organometallic Half-Sandwich Complexes Promote the formation of Linear Oligopeptides from Amino Acid Esters,” J. Chem. Eur. 2(12):1518-1526 (1996).
McCormick et al., “Synthesis, Structure, and Disproportionation of Labile (η6-C6H6)Ru(CH3CN)2CL+Salts,” Organometallics 12:610-612 (1993).
Morris et al., “Inhibition of Cancer Cell Growth by Ruthenium (II) Arene Complexes,” J. Med. Chem. 44:3616-3621 (2001).
Müller et al., “(η6-Aren)(η6-buta-1,3-dien)ruthenium(0)-Komplexe:Synthase and Eigenschaften sowie Kristallstruktur von (Benzol) (butadiene) ruthenium,” Journal of Organometallic Chemistry 458:219-224 (1993).
Pathak et al., “Synthesis and characterization of [{Ru(η6-C6Me6Cl2}2 (μ—DCBT)] and its reaction with EPb3(E=P, As, Sb), 2,2′-bipyridine and ,10′-phenanthroline,” Indian Journal of Chemistry 37A:165-168 (Feb. 1998).
Pertici et al., “Synthesis of the Arene Complex [{RuCl2(η6-o-MeC6H4CO2Me)}2] and Separation of its Diasterometric (-)(S)-1-Phenylethylamine Adducts,” J. Chem. Soc. Dalton Trans. 315-320 (1988).
Sava, “Ruth
Chen Haimei
Jodrell Duncan
Morris Robert Edward
Sadler Peter John
Berch Mark L.
Fish & Richardson P.C.
University Court, The University of Edinburgh
LandOfFree
Half-sandwich ruthenium (II) compounds comprising nitrogen... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Half-sandwich ruthenium (II) compounds comprising nitrogen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Half-sandwich ruthenium (II) compounds comprising nitrogen... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3507745